Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Total Liabilities (2024 - 2026)

Updated

Hemab Therapeutics Holdings (COAG) posted Total Liabilities of $13.44 million for Q3 2026, down 0.5% from the prior quarter.

Analysis

Hemab Therapeutics Holdings (COAG) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Hemab Therapeutics Holdings' Total Liabilities came in at $371.42 million, up 75.6% from FY2024.

  • In prior years, Hemab Therapeutics Holdings' Total Liabilities was $211.55 million in FY2024.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $13.51 million (Q2 2026), $373.88 million (Q1 2026) and $371.42 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 115.90 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 152.26 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 68.11 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 38.37 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 115.70 Bn
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn - 13.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 13.44 Mn
Jun 30, 2026 13.51 Mn
Mar 31, 2026 373.88 Mn
Dec 31, 2025 371.42 Mn
Dec 31, 2024 211.55 Mn
API Access

Hemab Therapeutics Holdings Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=COAG&period=max&api_key=YOUR_API_KEY